A Study on Ayurvedic Treatments for Reducing Inflammation in Rheumatoid Arthritis

Efficacy Of Manjistadi Kshara Basti And Virechana On Inflammatory Biomarkers In Amavata With Special Reference To Rheumatoid Arthritis A Randomised Exploratory Controlled Clinical Trial - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100032

Enrollment

Registered

2026-01-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient fulfilling the diagnostic criteria. Patient fit for Virechana and basti . Patient undergoing Virechana . Patient undergoing basti . Patients who are not on anti rheumatic drug from last 30 days.

Exclusion criteria

Exclusion criteria: K/C/O of Diabetes Mellitus, Irritable bowel Syndrome. Pregnant and lactating women. Patient on anti-lipidemic drugs.

Design outcomes

Primary

Measure	Time frame
Reduction in IL6 and Anti CCPTimepoint: 0th Day and 30th Day	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactDr Vishwanath S Wasedar

KAHERs Shri B M Kankanwadi Ayurveda Mahavidyalaya and Hospital shahapur belagavi 590003

Drvsayurveda@gmail.com8494946898

Outcome results